Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. May 15, 2023; 14(5): 560-564
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.560
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.560
COVID-19 vaccination and diabetic ketoacidosis
Beuy Joob, Academic Center, Sanitation1 Medical Academic Center, Bangkok 1033300, Thailand
Viroj Wiwanitkit, Community Medicine, DY Patil Vidhyapeeth, Pune 233230, India
Author contributions: Joob B and Wiwanitkit V contributed equally to this work; Joob B and Wiwanitkit V give the ideas; Joob B wrote and analyzed the data; Wiwanitkit V supervised; All authors have read and approve the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Beuy Joob, PhD, Adjunct Associate Professor, Academic Center, Sanitation1 Medical Academic Center, Bangkok 1033300, Thailand. beuyjoob@hotmail.com
Received: December 15, 2022
Peer-review started: December 15, 2022
First decision: January 17, 2023
Revised: February 1, 2023
Accepted: April 12, 2023
Article in press: April 12, 2023
Published online: May 15, 2023
Processing time: 151 Days and 5.2 Hours
Peer-review started: December 15, 2022
First decision: January 17, 2023
Revised: February 1, 2023
Accepted: April 12, 2023
Article in press: April 12, 2023
Published online: May 15, 2023
Processing time: 151 Days and 5.2 Hours
Core Tip
Core Tip: There has also been information on a potential connection between the coronavirus disease 2019 (COVID-19) vaccine and diabetic ketoacidosis. Common symptoms include thirst, polydipsia, polyuria, palpitations, a lack of appetite, and weariness. In extremely rare clinical circumstances, a COVID-19 vaccine recipient may develop diabetes complications such as hyperglycemia and ketoacidosis.